Michael W. Bonney, a director at Alnylam Pharmaceuticals ($ALNY), sold shares on the open market fifteen times over the past year, totaling about $8.2 million. His most recent sale occurred on August 18, 2025. These sales rank 1,326th among 11,678 individual insiders by total value, compared to an average of $8.6 million per insider across about 6.4 transactions. Bonney made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | M | Common Stock | 11250 | $70.20 | 32,054.0000 | 127,651,000 | 54.08% | 0.01% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 11250 | $450.00 | 20,804.0000 | 127,651,000 | 35.10% | 0.01% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | M | Stock Option (right to buy) | 11250 | $0.00 | 0.0000 | 127,651,000 | 100.00% | 0.01% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | M | Common Stock | 11250 | $131.21 | 32,054.0000 | 127,651,000 | 54.08% | 0.01% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 549 | $267.14 | 31,505.0000 | 127,651,000 | 1.71% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 729 | $268.56 | 30,776.0000 | 127,651,000 | 2.31% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 245 | $269.79 | 30,531.0000 | 127,651,000 | 0.80% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 431 | $271.68 | 30,100.0000 | 127,651,000 | 1.41% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 660 | $273.16 | 29,440.0000 | 127,651,000 | 2.19% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 882 | $273.75 | 28,558.0000 | 127,651,000 | 3.00% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 301 | $275.63 | 28,257.0000 | 127,651,000 | 1.05% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 1263 | $277.16 | 26,994.0000 | 127,651,000 | 4.47% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 1239 | $278.01 | 25,755.0000 | 127,651,000 | 4.59% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 432 | $280.03 | 25,323.0000 | 127,651,000 | 1.68% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 372 | $281.10 | 24,951.0000 | 127,651,000 | 1.47% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 802 | $282.03 | 24,149.0000 | 127,651,000 | 3.21% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 1728 | $282.81 | 22,421.0000 | 127,651,000 | 7.16% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | S | Common Stock | 1617 | $283.83 | 20,804.0000 | 127,651,000 | 7.21% | 0.00% |
| May 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | M | Stock Option (right to buy) | 11250 | $0.00 | 0.0000 | 127,651,000 | 100.00% | 0.01% |
| May 8, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | A | Common Stock | 775 | $0.00 | 20,804.0000 | 127,651,000 | 3.87% | 0.00% |
| May 8, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | A | Stock Option (right to buy) | 1558 | $0.00 | 1,558.0000 | 127,651,000 | 9999.99% | 0.00% |
| May 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | BONNEY MICHAEL W | Director | A | Stock Option (right to buy) | 5228 | $0.00 | 5,228.0000 | 124,906,000 | 9999.99% | 0.00% |